Database : HANSEN
Search on : TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE [Subject descriptor]
References found : 4 [refine]
Displaying: 1 .. 4   in format [Detailed]

page 1 de 1

  1 / 4 HANSEN  
              next record last record
select
to print
Id:17512
Author:Pignataro, P; Rocha, A. da Silva; Nery, J. A. C; Miranda, A; Sales, A. M; Ferreira, H; Valentim, V; Suffys, P. N
Title:Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy ..-
Source:s.l; s.n; 2004. 4 p. .
Abstract:Reported here are the cases of two HIV-positive patients with skin lesions suggestive of leprosy, based on clinical and pathological analysis, which worsened during the few weeks following initiation of highly active antiretroviral therapy. The lesions improved after a few weeks of multidrug therapy for leprosy. Mycobacterium leprae was confirmed by polymerase chain reaction analysis of blood in case 1 and of a biopsy sample in case 2. Neither Mycobacterium avium complex nucleic acid, which is usually associated with immune restoration syndrome, nor mycobacterial cutaneous manifestations were detected in either case(AU).
Descriptors:Infecções Oportunistas Relacionadas com a AIDS/DT/MI
Terapia Anti-Retroviral de Alta Atividade
Infecções por HIV/*CO/*DT
Hipersensibilidade Tardia/ET
Inflamação/*ET
Hanseníase/*CO
Mycobacterium leprae
Limits:RELATO DE CASO
Location:BR191.1; 00417/s


  2 / 4 HANSEN  
              first record previous record next record last record
select
to print
Id:13734
Author:Lawn, S. D; Wood, C; Lockwood, D. N
Title:Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person ..-
Source:s.l; s.n; 2003. 2 p. ilus.
Abstract:Two months after starting highly active antiretroviral treatment (HAART), an individual with human immunodeficiency virus type 1 (HIV-1) infection and profound CD4+ T lymphocytopenia developed several erythematous plaques on his face, which were due to borderline tuberculoid leprosy with reversal reaction. The temporal association between the development of these lesions and changes in blood CD4+ lymphocyte count and plasma HIV-1 load observed during HAART strongly suggests that the presentation of leprosy resulted from immune reconstitution. (AU).
Descriptors:INFECCOES OPORTUNISTAS RELACIONADAS COM A AIDS/imunol
AGENTES ANTI-HIV/uso terap
TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE/ef adv
CONTAGEM DE LINFOCITO CD4
INFECCOES POR HIV/compl
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
HANSENIASE TUBERCULOIDE/etiol
HANSENIASE TUBERCULOIDE/imunol
IMUNIDADE/ef drogas
Limits:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09026/s


  3 / 4 HANSEN  
              first record previous record next record last record
select
to print
Id:13540
Author:Lawn, S. D; Wood, C; Lockwood, D. N
Title:Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person ..-
Source:s.l; s.n; Jan. 2003. 3 p. ilus.
Abstract:Two months after starting highly active antiretroviral treatment (HAART), an individual with human immunodeficiency virus type 1 (HIV-1) infection and profound CD4+ T lymphocytopenia developed several erythematous plaques on his face, which were due to borderline tuberculoid leprosy with reversal reaction. The temporal association between the development of these lesions and changes in blood CD4+ lymphocyte count and plasma HIV-1 load observed during HAART strongly suggests that the presentation of leprosy resulted from immune reconstitution. (AU).
Descriptors:HANSENIASE TUBERCULOIDE/etiol
HANSENIASE TUBERCULOIDE/imunol
INFECCOES POR HIV/compl
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
CONTAGEM DE LINFOCITO CD4
INFECCOES OPORTUNISTAS RELACIONADAS COM A AIDS/imunol
AGENTES ANTI-HIV/uso terap
TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE/ef adv
IMUNIDADE/ef drogas
Limits:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Location:BR191.1; 09166/s


  4 / 4 HANSEN  
              first record previous record
select
to print
Id:12316
Author:Geraminejad, Pedram; Memar, Omeed; Aronson, Iris; Rady, Peter L; Hengge, Ulrich; Tyring, Stephen K
Title:Kaposi's sarcoma and other manifestations of human herpesvirus 8 ..-
Source:s.l; s.n; Nov. 2002. 15 p. ilus, tab.
Abstract:Kaposi's sarcoma (KS) was described by Moritz Kaposi in 1872 and was known for an entire century as a rare disorder of older men usually of Eastern European, Mediterranean, and/or Jewish origin. In the early 1980s, the prevalence of KS began to increase dramatically and soon became the most common malignancy in patients with AIDS, especially those who were male homosexuals. In 1994, a new human herpesvirus (HHV) was found to be present in almost 100% of KS lesions. This virus was found to be a gammaherpesvirus, closely related to Epstein-Barr virus, and was designated HHV-8. Subsequently, HHV-8 DNA was found in almost all specimens of classic KS, endemic KS, and iatrogenic KS, as well as epidemic KS (ie, AIDS KS). It is now believed that HHV-8 is necessary, but not sufficient, to cause KS and that other factors such as immunosuppression play a major role. The use of highly active antiretroviral therapy (HAART) since 1996 has markedly reduced the prevalence of AIDS KS in western countries, but because 99% of the 40 million patients with AIDS in the world cannot afford HAART, KS is still a very common problem. Primary effusion lymphoma and multicentric Castleman's disease are also thought to be due to HHV-8. Although HHV-8 DNA has been described in a number of other cutaneous disorders, there is little evidence that HHV-8 is of etiologic significance in these diseases. The mechanism by which HHV-8 causes KS, primary effusion lymphoma, and multicentric Castleman's disease is not well understood but is thought to involve a number of molecular events, the study of which should further our understanding of viral oncology. (J Am Acad Dermatol 2002;47:641-55.) Learning objective: At the completion of this learning activity, participants should be familiar with Kaposi's sarcoma and other manifestations of human herpesvirus 8..
Descriptors:PRODUTOS DO GENE TAT
INFECÇOES POR HERPESVIRIDAE
HIPERPLASIA DO LINFONODO GIGANTE
INTERLEUCINA-6
LINFOMA DE CÉLULA-B
LINFOMA DE CÉLULA-B
SARCOMA DE KAPOSI
SARCOMA DE KAPOSI
SARCOMA DE KAPOSI
SARCOMA DE KAPOSI
TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE
FASES DE LEITURA ABERTA/fisiologia
HERPESVIRUS 8 HUMANO/fisiologia
ESTUDOS SOROEPIDEMIOLOGICOS
Limits:HUMANO
Location:BR191.1; 0274/cme



page 1 de 1
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information